Mutational Signatures (v3.6 - May 2026)
SBS113 · GRCh37 · COSMIC v104
Mutational profile
Genome: GRCh37
Genome: GRCh38
Genome: mm9
Genome: mm10
Genome: rn6
Genome: mm39
Genome: rn7
Mutational profile using the conventional 96 mutation type classification. This classification is based on the six substitution subtypes: C>A, C>G, C>T, T>A, T>C, and T>G, as well as the nucleotides immediately 5’ and 3’ to the mutation.
Each of the substitutions is referred to by the pyrimidine of the mutated Watson—Crick base pair. Incorporating information on the bases immediately 5’ and 3’ to each mutated base generates 96 possible mutation types (6 types of substitution x 4 types of 5’ base x 4 types of 3’ base). Mutational signatures are displayed and reported based on the observed trinucleotide frequency of the genome, i.e., representing the relative proportions of mutations generated by each signature based on the actual trinucleotide frequencies of the corresponding reference genome.
Proposed aetiology
Ganciclovir exposure
Acceptance criteria
| Background | Identification study | First included in COSMIC | |
|---|---|---|---|
| de Kanter et al. 2021 Cell Stem Cell | v3.6 | ||
| Identification | NGS technique | Different variant callers | Multiple sequencing centres |
| WGS | No | Yes | |
| Technical validation | Validated in orthogonal techniques | Replicated in additional studies | Extended context enrichment |
| Yes | No | - | |
| Proposed aetiology | Mutational process | Support | |
| Ganciclovir treatment exposure | Experimental confirmation | ||
| Experimental validation | Experimental study | Species | |
| de Kanter et al. 2021 Cell Stem Cell | Human | ||
Summary of the technical and experimental evidence available in the scientific literature regarding the validation of the mutational signature.
Tissue distribution
Discovered in cancers of transplantation recipients